Residents Perspective & Journal Articles

• Key Updates in Early Breast Cancer From SABCS 2024   Key updates from SABCS 2024 in early breast cancer include the COMET study on DCIS recurrence, INSEMA trial on SLNB omission, and OlympiA updates on adjuvant olaparib, shared by Dr Harold Burstein.
  Medscape, January 09, 2025
• Simple Text Reminders Help Increase Vaccine Uptake   Dr Maurie Markman discusses the importance of implementation research to address pragmatic questions.
  Medscape Oncology, January 09, 2025
• Stay Informed: What Is Obesity and How Should It Be Treated?   Dr Priya Jaisinghani discusses obesity.
  Medscape Internal Medicine, January 08, 2025
• Skills Lab: Assessing the Introduction and Methods Sections   Dr Bishal Gyawali discusses tips for reading a phase 3 clinical trial publication, focusing on the introduction and methods sections.
  Medscape Oncology, January 08, 2025
• The Year’s Notable Guidelines: Highlights for Primary Care   Dr Neil Skolnik reviews key guidelines from 2024 that should not be missed by primary care clinicians.
  Medscape Family Medicine, January 08, 2025
• Can GLP-1s Reduce Alzheimer’s Disease Risk? Caroline Messer, MD, shares how she prescribed a GLP-1 receptor agonist to a patient as possible low-risk prophylaxis against Alzheimer’s disease.
  Medscape Diabetes & Endocrinology, January 08, 2025
• Sports Injuries of the Hip in Primary Care   Bursitis or tendinopathy? FABER or FADIR? The Curbsiders share tips from an expert on how to assess and manage sport-related hip pain.
  The Curbsiders, January 07, 2025
• Making Sense of Mixed Messages on Drinking   Medscape’s Neha Pathak, MD, and George Koob, PhD, Director of the National Institute on Alcohol Abuse and Alcoholism, break down the latest guidance on alcohol intake.
  Medscape Family Medicine, January 07, 2025
• The Year’s Hottest Topics in Pediatric Medicine As we head into 2025, Dr William Basco comments on 2024’s most important news for pediatric clinicians.
  Medscape Pediatrics, January 07, 2025
• History Repeats? Lead Pollution and the Roman Economy   A story hidden in the icy layers of the Arctic may have lessons for cognitive health in the modern era.
  Medscape, January 07, 2025
• HBP: What Happened in the 1930s Should Stay There   Christopher Labos, MD CM, MSc, makes sense of nearly 100 years of blood pressure recommendations.
  Medscape Family Medicine, January 03, 2025
• How Do You Feel: Should Docs Disclose Their Mental Health?   Drs Andrew Wilner and Jessica Gold discuss her book on mental health among healthcare professionals and the role of a chief wellness officer.
  Medscape Neurology, January 03, 2025
• Three-Year Medical School Can Work: Ethicist   Ethicist Art Caplan discusses the benefits of a 3-year medical school curriculum.
  Medscape Business of Medicine, January 03, 2025
• Updates in ER-Positive Breast Cancer From SABCS 2024   Updates in ER+ breast cancer from SABCS 2024 include the EMBER-3 trial of novel oral SERD imlunestrant, PATINA trial results, and updated analysis from TAILORx, as reported by Dr Harold Burstein.
  Medscape, January 02, 2025
• Benefits of Playing Drums: Physical, Mental, and Social   Professor David Kerr discusses the benefits of drumming.
  Medscape Oncology, January 02, 2025
• ASH 2024: Clinical Impact of Promising Treatments for PNH   Dr Ilene Weitz reviews data on novel agents and their efficacy in enhancing quality of life and minimizing breakthrough events.
  Medscape, January 02, 2025
• Key Studies in Acute Lymphoblastic Leukemia From ASH 2024   Highlights in acute lymphoblastic leukemia (ALL) from ASH 2024 include significant results for blinatumomab in pediatric ALL, potential use of asciminib, and frontline use of CAR-T cell therapy.
  Medscape, January 02, 2025
• SABCS 2024: Clinical Impact of Advances in HR+ Breast Cancer   Drs Armaghani and Henry share SABCS 2024 highlights, including anticipated presentations, quick takeaways, and insights into how new research will affect their patients.
  Medscape, January 02, 2025
• Paroxysmal Nocturnal Hemoglobinuria Takeaways From ASH 2024   Symptom improvement with novel therapies and better patient-reported outcomes, as well as breakthrough hemolysis control, are among the paroxysmal nocturnal hemoglobinuria highlights from ASH 2024.
  Medscape, December 30, 2024
• Novel Insights in Thrombotic Disorders From ASH 2024   Rilzabrutinib and eltrombopag in immune thrombocytopenia, and the place of oral direct anticoagulation in venous thromboembolism, are among the novel insights in thrombotic disorders from ASH 2024.
  Medscape, December 30, 2024